User profiles for Amir Ben-Tov

Amir Ben Tov

Tel Aviv University
Verified email at tauex.tau.ac.il
Cited by 3650

Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats

S Abramovitch, L Dahan-Bachar, E Sharvit, Y Weisman… - Gut, 2011 - gut.bmj.com
Background and aim Hepatic stellate cells (HSCs) are key participants in liver fibrosis
development. 1,25(OH) 2 D 3 , the active form of vitamin D, has antiproliferative properties and …

[HTML][HTML] Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections

…, R Shlezinger, G Perez, R Lotan, A Peretz, A Ben-Tov… - MedRxiv, 2021 - medrxiv.org
Background Reports of waning vaccine-induced immunity against COVID-19 have begun to
surface. With that, the comparable long-term protection conferred by previous infection with …

Incidence of rash after amoxicillin treatment in children with infectious mononucleosis

A Chovel-Sella, A Ben Tov, E Lahav, O Mor… - …, 2013 - publications.aap.org
… Drs Chovel-Sella and Ben Tov contributed equally to the article and are both listed as first …
the final article as submitted; Dr Ben Tov supervised and contributed to acquisition of the data …

Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities

…, R Katz, E Herzel, T Berman-Zilberstein, A Ben-Tov… - medrxiv, 2021 - medrxiv.org
Vaccinations are considered the major tool to curb the current SARS-CoV-2 pandemic. A
randomized placebo-controlled trial of the Pfizer BNT162b2 vaccine has demonstrated a 95% …

[HTML][HTML] Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine

…, Z Golan, L Schreiber, T Wolf, V Nadler, A Ben-Tov… - Nature medicine, 2021 - nature.com
Beyond their substantial protection of individual vaccinees, coronavirus disease 2019 (COVID-19)
vaccines might reduce viral load in breakthrough infection and thereby further …

[HTML][HTML] Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine

…, N Kalkstein, A Peretz, G Perez, A Ben-Tov… - Nature …, 2021 - nature.com
The short-term effectiveness of a two-dose regimen of the BioNTech/Pfizer mRNA BNT162b2
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine was widely …

The effectiveness of the two-dose BNT162b2 vaccine: analysis of real-world data

…, T Patalon, S Gazit, A Ben-Tov… - Clinical Infectious …, 2022 - academic.oup.com
Background Coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccines
were shown to be highly efficacious in preventing the disease in randomized controlled trials; …

Association of BNT162b2 COVID-19 vaccination during pregnancy with neonatal and early infant outcomes

…, G Chodick, Y Segal, SSB David, A Ben-Tov - JAMA …, 2022 - jamanetwork.com
Importance Pregnant women were excluded from the BNT162b2 messenger RNA (mRNA)
COVID-19 vaccine (Pfizer-BioNTech) preauthorization trial. Therefore, observational data on …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) naturally acquired immunity versus vaccine-induced immunity, reinfections versus breakthrough …

…, G Perez, R Lotan, A Peretz, A Ben-Tov… - Clinical Infectious …, 2022 - academic.oup.com
Background Waning of protection against infection with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) conferred by 2 doses of the BNT162b2 vaccine begins shortly …

The incidence of SARS-CoV-2 reinfection in persons with naturally acquired immunity with and without subsequent receipt of a single dose of BNT162b2 vaccine: a …

…, G Perez, R Lotan, A Peretz, A Ben-Tov… - Annals of Internal …, 2022 - acpjournals.org
Background: There is insufficient evidence regarding the magnitude and durability of
protection conferred by a combined effect of naturally acquired immunity after SARS-CoV-2 …